Form 4: Neeleman Stephen Reports Changes in Beneficial Ownership of HealthEquity, Inc. Shares

Stephen Neeleman, Founder and Vice Chairman of HealthEquity, Inc., reports transactions involving common stock and restricted stock units, resulting in changes to his beneficial ownership.

Summary

• Stephen Neeleman, Founder and Vice Chairman of HealthEquity, Inc., filed a Form 4 detailing changes in his beneficial ownership of the company's stock.
• On April 2, 2025, Neeleman acquired 14,086 shares of common stock and 21,969 restricted stock units, each representing a contingent right to receive one share of common stock.
• Also on April 2, 2025, 21,969 restricted stock units vested.
• On April 3, 2025, Neeleman disposed of 1,316 shares of common stock at a weighted average price of $83.8754.
• Following these transactions, Neeleman directly owns 122,661 shares of common stock.
• Neeleman also indirectly owns 553,235 shares through the Stephen and Christine Neeleman Trust and 203,000 shares through Neeleman Family Holdings, LLC.
• Neeleman also holds options to buy 19,897 shares at $41.28, 14,228 shares at $61.72, and 15,337 shares at $73.61, all of which are immediately exercisable.

Sentiment

Score: 6

Explanation: The sentiment is neutral. The filing primarily reflects routine transactions. The acquisition of shares and vesting of restricted stock units are mildly positive, while the disposal of shares is mildly negative. Overall, it doesn't strongly indicate a bullish or bearish outlook.

Positives

• The vesting of 21,969 restricted stock units indicates continued alignment of Neeleman's interests with the company's performance.

Negatives

• The disposal of 1,316 shares, while a small amount, could be interpreted negatively by some investors.

Risks

• Significant changes in insider ownership could potentially create uncertainty among investors.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. Investors often monitor these filings to gauge management's sentiment and confidence in the company's prospects.

Comparison to Industry Standards

• Comparing Neeleman's transactions to those of other executives in similar healthcare technology companies could provide insights into whether these actions are typical or indicative of a specific trend.
• For example, reviewing Form 4 filings of executives at companies like Teladoc Health or Livongo (prior to its acquisition by Teladoc) could offer a comparative perspective.

Stakeholder Impact

• The transactions reported in the Form 4 filing may influence investor sentiment and potentially impact the company's stock price.

Key Dates

Keywords

HealthEquity, Neeleman, Beneficial Ownership, Form 4, Stock Options, Restricted Stock Units, Insider Trading